← Back to Patent Explorer
US2864744A Expired / Lapsed US ⏱️ 0.0 years remaining

Penicillin in solid dosage unit form

Assignee: Wyeth LLC
•
Filing: 1955-12-05
•
Granted: 1958-12-16
•
Expires: 1975-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Jack J Mendelsohn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:32
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/425; A61K31/429; A61K31/43

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 65 words
A THERAPEUTIC DOSAGE UNIT IN SOLID COMPRESSED FORM COMPRISING AS A UNIFORM MIXTURE A THERAPEUTIC AMOUNT OF WATER-SOLUBLE PENICILLIN SALT, A WATER-INSOLUBLE AND ACIDINSOLUBLE PROTEIN WHICH IS SOLUBLE IN A SATURATED AQUEOUS SOLUTION OF THE PENICILLIN SALT, ANACID-INSOLUBLE, ALKALI SOLUBLE MEDICINAL SHELLAC, A BUFFERING AGENT, AND EXCIPIENTS, SAID DOSAGE UNIT BEING SUBSTANTIALLY RESISTANT TO THE ACTION OF THE GASTRIC JUICE WHILE READILY DISINTEGRATING AND JUICE.
Claim 2
Dependent Claim 65 words
A THERAPEUTIC DOSAGE UNIT IN SOLID COMPRESSED FORM COMPRISING AS A UNIFORM MIXTURE A THERAPEUTIC AMOUNT OF WATER-SOLUBLE PENICILLIN SALT, A WATER-INSOLUBLE AND ACIDINSOLUBLE PROTEIN WHICH IS SOLUBLE IN A SATURATED AQUEOUS SOLUTION OF THE PENICILLIN SALT, ANACID-INSOLUBLE, ALKALI SOLUBLE MEDICINAL SHELLAC, A BUFFERING AGENT, AND EXCIPIENTS, SAID DOSAGE UNIT BEING SUBSTANTIALLY RESISTANT TO THE ACTION OF THE GASTRIC JUICE WHILE READILY DISINTEGRATING AND JUICE.
Claim 3
Dependent Claim 64 words
A THERAPEUTIC DOSAGE UNIT IN SOLID COMPRESSED FORM COMPRISING AS A UNIFORM MIXTURE ABOUT 33% BY WEIGHT OF AN ALKALI METAL SALT OF PENICILLIN, ABOUT 20% BY WEIGHT OF CASEIN, ABOUT 7% BY WEIGHT OF BUFFERS AND ABOUT 10% BY WEIGHT OF WHITE SHELLAC, THE REMAINDER OF THE UNIT BEING EXCIPIENTS, THE PENICILLIN, CASEIN AND WHITE SHELLAC BEING HOMOGENEOUSLY DISPERSED THROUGHOUT THE DOSAGE UNIT.
Claim 4
Dependent Claim 64 words
A THERAPEUTIC DOSAGE UNIT IN SOLID COMPRESSED FORM COMPRISING AS A UNIFORM MIXTURE ABOUT 33% BY WEIGHT OF AN ALKALI METAL SALT OF PENICILLIN, ABOUT 20% BY WEIGHT OF CASEIN, ABOUT 7% BY WEIGHT OF BUFFERS AND ABOUT 10% BY WEIGHT OF WHITE SHELLAC, THE REMAINDER OF THE UNIT BEING EXCIPIENTS, THE PENICILLIN, CASEIN AND WHITE SHELLAC BEING HOMOGENEOUSLY DISPERSED THROUGHOUT THE DOSAGE UNIT.

References Cited (Backward Citations)

US2438106A Cited
US2449039A Cited
GB629281A Cited
US2566200A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1961-12-15 1962-06-16 1962-12-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1965-12-15 1966-06-16 1966-12-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1969-12-15 1970-06-16 1970-12-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag